{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:05:16Z","timestamp":1761843916492},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.atherosclerosis.2009.05.016","type":"journal-article","created":{"date-parts":[[2009,5,23]],"date-time":"2009-05-23T08:17:19Z","timestamp":1243066639000},"page":"559-566","source":"Crossref","is-referenced-by-count":27,"title":["Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case\u2013control study"],"prefix":"10.1016","volume":"207","author":[{"given":"Paul N.","family":"Hopkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Nazeem","family":"Nanjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily L.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"McGinty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliot A.","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven C.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.05.016_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1073\/pnas.74.3.837","article-title":"Structure of human serum lipoproteins inferred from compositional analysis","volume":"74","author":"Shen","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.05.016_bib3","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/clinchem\/27.12.2008","article-title":"Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma","volume":"27","author":"Wilson","year":"1981","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.05.016_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/clinchem\/36.1.15","article-title":"Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints","volume":"36","author":"Warnick","year":"1990","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.05.016_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.clinbiochem.2004.03.008","article-title":"Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population","volume":"37","author":"Tremblay","year":"2004","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.05.016_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0009-8981(85)90091-9","article-title":"Estimation of VLDL cholesterol in hyperlipidemia","volume":"151","author":"Wilson","year":"1985","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.05.016_bib7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/clinchem\/35.5.808","article-title":"Composition of very-low-density lipoproteins in non-insulin-dependent diabetes mellitus","volume":"35","author":"Ishibashi","year":"1989","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2009.05.016_bib8","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/clinchem\/37.8.1394","article-title":"Influence of intermediate-density lipoproteins on the accuracy of the Friedewald formula","volume":"37","author":"Senti","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib9","first-page":"413","article-title":"The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis, and coronary disease","volume":"2","author":"Gofman","year":"1954","journal-title":"Plasma"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.05.016_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)35376-1","article-title":"A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum","volume":"22","author":"Chapman","year":"1981","journal-title":"J Lipid Res"},{"issue":"658","key":"10.1016\/j.atherosclerosis.2009.05.016_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bmj.2.5658.665","article-title":"Type 3 hyperlipoproteinaemia","volume":"2","author":"Borrie","year":"1969","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7326\/0003-4819-82-2-158","article-title":"The biochemical, clinical, and genetic features of type III hyperlipoproteinemia","volume":"82","author":"Morganroth","year":"1975","journal-title":"Ann of Intern Med"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1172\/JCI107333","article-title":"Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction","volume":"52","author":"Hazzard","year":"1973","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7326\/0003-4819-82-2-141","article-title":"Broad-beta disease (type III hyperlipoproteinemia) in a large kindred, evidence for a monogenic mechanism","volume":"82","author":"Hazzard","year":"1975","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0009-8981(75)80004-0","article-title":"A longitudinal assessment of lipid ratios in the diagnosis of type III hyperlipoproteinaemia","volume":"58","author":"Mishkel","year":"1975","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.05.016_bib17","first-page":"104","article-title":"Clinical features of type III hyperlipoproteinaemia","volume":"26","author":"Stuyt","year":"1983","journal-title":"Netherlands J Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.05.016_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF00186624","article-title":"Clinical features of type III hyperlipoproteinemia: analysis of 64 patients","volume":"71","author":"Feussner","year":"1993","journal-title":"Clin Invest"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2009.05.016_bib19","first-page":"743","article-title":"Apolipoprotein E to B ratio: a marker for type III hyperlipoproteinaemia","volume":"31","author":"Marz","year":"1993","journal-title":"Eur J Clin Chem Clin Biochem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.05.016_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0021-9150(95)05633-5","article-title":"Prevalence and association of atherosclerosis at three different arterial sites in patients with type III hyperlipoproteinemia","volume":"119","author":"Dobmeyer","year":"1996","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.05.016_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00019501-200208000-00002","article-title":"An increased number of very-low-density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate-density lipoprotein or low-density lipoprotein","volume":"13","author":"Koba","year":"2002","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib22","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1161\/01.ATV.17.11.2630","article-title":"Prevalence of double pre-beta lipoproteinemia in hyperlipidemic patients is influenced by gender, menopausal status, and apoE phenotype","volume":"17","author":"Cohn","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2009.05.016_bib23","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/01.ATV.19.10.2474","article-title":"Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins","volume":"19","author":"Cohn","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7326\/0003-4819-82-2-150","article-title":"Type III hyperlipoproteinemia: an analysis of two contemporary definitions","volume":"82","author":"Fredrickson","year":"1975","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2009.05.016_bib25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/BF01489475","article-title":"Evaluation of the classical methods for the diagnosis of type III hyperlipoproteinemia","volume":"55","author":"Patsch","year":"1977","journal-title":"Klin Wochenschr"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-8981(77)90190-5","article-title":"Type III hyperlipoproteinemia: a comparative study of current diagnostic techniques","volume":"75","author":"Albers","year":"1977","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2009.05.016_bib27","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jacc.2004.11.062","article-title":"Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease","volume":"45","author":"Hopkins","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.05.016_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9149(00)01429-6","article-title":"Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia","volume":"87","author":"Hopkins","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib29","unstructured":"Lipid Research Clinics Manual of laboratory operations: Lipid Research Clinics Program, Volume 1. In: National Institutes of Health, Bethesda, MD, 1974."},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib30","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/clinchem\/35.7.1486","article-title":"A rapid micro-scale procedure for determination of the total lipid profile","volume":"35","author":"Wu","year":"1989","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib31","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","article-title":"Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol","volume":"28","author":"Warnick","year":"1982","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.05.016_bib32","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.ATV.16.9.1203","article-title":"Effects of intravenous infusion of lipid-free apo A-I in humans","volume":"16","author":"Nanjee","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib33","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.ATV.11.5.1137","article-title":"Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2, Evidence for a gene-gene interaction","volume":"11","author":"Hopkins","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib34","series-title":"Laboratory medicine. The selection and interpretation of clinical laboratory studies","first-page":"476","article-title":"Dyslipidemias","author":"Hopkins","year":"1994"},{"issue":"Suppl. I","key":"10.1016\/j.atherosclerosis.2009.05.016_bib35","first-page":"I","article-title":"Type III hyperlipidemia and lipoprotein remnants in early onset familial coronary artery disease","volume":"98","author":"Hopkins","year":"1998","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2009.05.016_bib36","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0026-0495(82)90074-9","article-title":"The plasma lipoproteins as risk factors: comparison of electrophoretic and ultracentrifugation results","volume":"31","author":"Hulley","year":"1982","journal-title":"Metabolism"},{"issue":"1 Pt 2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib37","first-page":"I4","article-title":"Populations and methods for assessing dyslipoproteinemia and its correlates, The Lipid Research Clinics Program Prevalence Study","volume":"73","author":"Williams","year":"1986","journal-title":"Circulation"},{"issue":"1 Pt 2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib38","first-page":"I12","article-title":"Patterns of dyslipoproteinemia in selected North American populations, The Lipid Research Clinics Program Prevalence Study","volume":"73","author":"LaRosa","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib39","series-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. The metabolic and molecular bases of inherited disease","first-page":"2835","author":"Mahley","year":"2001"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2009.05.016_bib40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0002-9149(01)02047-1","article-title":"Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease","volume":"88","author":"Schaefer","year":"2001","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.05.016_bib41","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/01.ATV.0000029972.42487.42","article-title":"Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis","volume":"22","author":"Bjorkegren","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.05.016_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0021-9150(03)00025-X","article-title":"Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders","volume":"168","author":"Onat","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib43","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0022-2275(20)38428-5","article-title":"Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits","volume":"29","author":"Nordestgaard","year":"1988","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.05.016_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0021-9150(00)00634-1","article-title":"Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages","volume":"155","author":"Milosavljevic","year":"2001","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.05.016_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1388-1981(02)00355-4","article-title":"VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass","volume":"1631","author":"Milosavljevic","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"28","key":"10.1016\/j.atherosclerosis.2009.05.016_bib46","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.2174\/138161205774580732","article-title":"Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development","volume":"11","author":"Botham","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.05.016_bib47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00041433-199510000-00008","article-title":"Postprandial state and atherosclerosis","volume":"6","author":"Ebenbichler","year":"1995","journal-title":"Curr Opin Lipidol"},{"issue":"6A","key":"10.1016\/j.atherosclerosis.2009.05.016_bib48","doi-asserted-by":"crossref","first-page":"9H","DOI":"10.1016\/S0002-9149(01)01831-8","article-title":"Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus","volume":"88","author":"Ginsberg","year":"2001","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.05.016_bib49","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jacc.2003.11.065","article-title":"Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: a long-term follow-up study","volume":"43","author":"Sposito","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2009.05.016_bib50","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI119456","article-title":"Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice, Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E","volume":"99","author":"Ebara","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.05.016_bib51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2004.06.011","article-title":"Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia","volume":"177","author":"Cohn","year":"2004","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.05.016_bib52","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.ATV.0000203519.25116.54","article-title":"Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics","volume":"26","author":"Chan","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.05.016_bib53","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1371\/journal.pbio.0040113","article-title":"Lipoprotein genotype and conserved pathway for exceptional longevity in humans","volume":"4","author":"Atzmon","year":"2006","journal-title":"PLoS Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib54","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.81.2.470","article-title":"Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts, lipid and nonlipid factors","volume":"81","author":"Blankenhorn","year":"1990","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.05.016_bib55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.90.1.42","article-title":"Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild\/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin","volume":"90","author":"Hodis","year":"1994","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2009.05.016_bib56","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","article-title":"VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.05.016_bib57","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1194\/jlr.M200145-JLR200","article-title":"ApoC-III gene polymorphisms and risk of coronary artery disease","volume":"43","author":"Olivieri","year":"2002","journal-title":"J Lipid Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.05.016_bib58","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1194\/jlr.M300253-JLR200","article-title":"Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease","volume":"44","author":"Olivieri","year":"2003","journal-title":"J Lipid Res"},{"issue":"5908","key":"10.1016\/j.atherosclerosis.2009.05.016_bib59","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2009.05.016_bib60","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.108.784785","article-title":"Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction","volume":"118","author":"Kawakami","year":"2008","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2009.05.016_bib61","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/CIRCULATIONAHA.108.794081","article-title":"Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolism","volume":"118","author":"Bobik","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.05.016_bib62","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ejhg.2008.202","article-title":"The expression of type III hyperlipoproteinemia: involvement of lipolysis genes","volume":"17","author":"Henneman","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2009.05.016_bib63","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF02534177","article-title":"Composition of plasma and nascent very low density lipoprotein from perfused livers of hypercholesterolemic squirrel monkeys","volume":"15","author":"Nicolosi","year":"1980","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib64","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/hep.510230204","article-title":"Bile acids suppress the secretion of very-low-density lipoprotein by human hepatocytes in primary culture","volume":"23","author":"Lin","year":"1996","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.05.016_bib65","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/S0022-2275(20)41088-0","article-title":"Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells","volume":"36","author":"Avramoglu","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib66","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-2275(20)37589-1","article-title":"Role of cholesterol in regulating apolipoprotein B secretion by the liver","volume":"37","author":"Thompson","year":"1996","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2009.05.016_bib67","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/01.ATV.17.11.2589","article-title":"Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs","volume":"17","author":"Burnett","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2009.05.016_bib68","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1210\/en.140.11.5293","article-title":"The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs","volume":"140","author":"Burnett","year":"1999","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0021-9150(00)00407-X","article-title":"Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes","volume":"153","author":"Isusi","year":"2000","journal-title":"Atherosclerosis"},{"issue":"1\u20133","key":"10.1016\/j.atherosclerosis.2009.05.016_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1388-1981(00)00151-7","article-title":"Cholesterol and hepatic lipoprotein assembly and secretion","volume":"1529","author":"Kang","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.05.016_bib71","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1039\/b700706j","article-title":"The physiological and molecular regulation of lipoprotein assembly and secretion","volume":"3","author":"Blasiole","year":"2007","journal-title":"Mol Biosyst"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib72","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1194\/jlr.M600170-JLR200","article-title":"Cholesterol feeding strongly reduces hepatic VLDL-triglyceride production in mice lacking the liver X receptor alpha","volume":"48","author":"van der Veen","year":"2007","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib73","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0005-2760(79)90073-0","article-title":"In vivo transfer of cholesterol esters from high density lipoproteins to very low density lipoproteins in man","volume":"573","author":"Nestel","year":"1979","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib74","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1172\/JCI110789","article-title":"Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma","volume":"71","author":"Fielding","year":"1983","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.05.016_bib75","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1194\/jlr.M300511-JLR200","article-title":"Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans","volume":"45","author":"Schwartz","year":"2004","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2009.05.016_bib76","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1161\/01.ATV.17.11.2685","article-title":"HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum","volume":"17","author":"Fournier","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2009.05.016_bib77","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehm062","article-title":"High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides","volume":"28","author":"Borggreve","year":"2007","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.05.016_bib78","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.2337\/diabetes.54.12.3554","article-title":"Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides","volume":"54","author":"de Vries","year":"2005","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2009.05.016_bib79","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1172\/JCI118751","article-title":"Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels","volume":"97","author":"Zhong","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib80","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.ATV.17.6.1053","article-title":"Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan, Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity","volume":"17","author":"Hirano K-i","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2009.05.016_bib81","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.102.18.2197","article-title":"Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study","volume":"102","author":"Agerholm-Larsen","year":"2000","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2009.05.016_bib82","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1210\/jc.2005-2322","article-title":"An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study","volume":"91","author":"Borggreve","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2009.05.016_bib83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijcard.2004.08.065","article-title":"Carriers of three polymorphisms of cholesteryl ester transfer protein gene are at increased risk to coronary heart disease in a Chinese population","volume":"103","author":"Zheng","year":"2005","journal-title":"Int J Cardiol"},{"issue":"5 Pt 1","key":"10.1016\/j.atherosclerosis.2009.05.016_bib84","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1006\/pmed.1998.0340","article-title":"A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency","volume":"27","author":"Moriyama","year":"1998","journal-title":"Prev Med"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib85","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199801083380203","article-title":"for the Regression Growth Evaluation Statin Study Group: the role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis","volume":"338","author":"Kuivenhoven","year":"1998","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.05.016_bib86","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/01.ATV.20.5.1323","article-title":"Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study","volume":"20","author":"Ordovas","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2009.05.016_bib87","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/01.ATV.0000024566.57589.2E","article-title":"Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial","volume":"22","author":"Brousseau","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2009.05.016_bib88","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/jama.290.15.2030","article-title":"Unique lipoprotein phenotype and genotype associated with exceptional longevity","volume":"290","author":"Barzilai","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2009.05.016_bib89","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0735-1097(03)00408-X","article-title":"Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease","volume":"41","author":"Blankenberg","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2009.05.016_bib90","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0735-1097(03)00393-0","article-title":"Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk, do they add up yet?","volume":"41","author":"Anderson","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2009.05.016_bib91","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1194\/jlr.M300520-JLR200","article-title":"A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly","volume":"45","author":"Curb","year":"2004","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2009.05.016_bib92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2005.01.015","article-title":"CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease","volume":"181","author":"Thompson","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.05.016_bib93","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe078029","article-title":"CETP Inhibitors to Increase HDL Cholesterol Levels","author":"Tall","year":"2007","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2009.05.016_bib94","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2009.05.016_bib95","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0735-1097(02)02017-X","article-title":"Contribution of major cardiovascular risk factors to familial premature coronary artery disease, the GENECARD project","volume":"40","author":"Jomini","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2009.05.016_bib96","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9149(00)01303-5","article-title":"Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (The Health Family Tree Study and the NHLBI Family Heart Study)","volume":"87","author":"Williams","year":"2001","journal-title":"Am J Cardiol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009004110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009004110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T04:10:55Z","timestamp":1633493455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009004110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0021915009004110"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.05.016","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}